Company Announcements

Latest announcements

Date and timeCompanyHeadlineSource
CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual MeetingPR Newswire
Median PFS Trending Beyond One Year: Leads Biolabs' LBL-034 Showcases Breakthrough Clinical Data in Oral Presentation at the 2025 ASH Annual MeetingPR Newswire
Rio Tinto’s first Pilbara-made rail car built by Gemco in KarrathaBusiness Wire
Cochin Shipyard to build next-generation electric TRAnsverse tugs for SvitzerGlobeNewswire
Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: The FX Super One First Pre-Production Vehicles Roll-off Ceremony is Scheduled for December 21 at the Company’s Hanford, CA FactoryGlobeNewswire
ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple MyelomaPR Newswire
CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual MeetingPR Newswire
Edgewater Wireless Announces Completion of Eleventh and Twelfth Payments of Debenture InterestBusiness Wire
Linux Foundation Welcomes Mitsubishi Electric as Gold Member During Open Source Summit JapanPR Newswire
Sustainability Focus Session 2025Business Wire
Matthews International Provides Update on Actions to Create Shareholder Value and Addresses Director NominationsPR Newswire
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell MalignanciesBusiness Wire
HUTCHMED Announces Expanded Coverage on National Reimbursement Drug List and Inclusion in the First Commercial Insurance Drug List in ChinaGlobeNewswire
Structure Therapeutics to Report Data from ACCESS Clinical Program of Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron, on December 8, 2025GlobeNewswire
RNS announcements are delayed by up to an hour.
...